SimpleTrials

Executive Summary

SimpleTrials is a US-based digital health company offering a subscription-based Clinical Trial Management System (CTMS) and electronic Trial Master File (eTMF) platform. Founded in 2015, the company targets small to mid-sized sponsors, CROs, and clinical trial sites with an affordable, easy-to-use cloud solution starting at $599/month. In a market dominated by legacy systems, SimpleTrials differentiates through simplicity and cost-effectiveness, enabling smaller organizations to conduct trials with less overhead. However, the company faces stiff competition from established players like Medidata and Veeva, and its lack of disclosed funding suggests bootstrapped operations, which may limit its ability to scale and innovate rapidly. Looking ahead, SimpleTrials can capitalize on the growing demand for decentralized and hybrid trials, which require flexible CTMS solutions. The company's focus on affordability positions it well for the expanding segment of small biotechs and sites. Near-term catalysts include product enhancements to support decentralized trial workflows, potential partnerships with site networks to expand customer base, and achievement of a significant customer milestone such as onboarding its 100th trial. While the company operates in a lucrative market, execution and capital constraints remain key risks.

Upcoming Catalysts (preview)

• Q3 2026Launch of decentralized trial module with ePRO/eCOA integration70% success
• Q4 2026Partnership with leading site network to expand adoption60% success
• Q2 2026Customer milestone: 100th trial managed on platform80% success